Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
As of close of business last night, Beam Therapeutics Inc’s stock clocked out at $17.66, down -1.31% from its previous closing price of $17.89. In other words, the price has decreased by -$1.31 from its previous closing price. On the day, 1.07 million shares were traded.
Ratios:
To gain a deeper understanding of BEAM’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.81 and its Current Ratio is at 8.81. In the meantime, Its Debt-to-Equity ratio is 0.14 whereas as Long-Term Debt/Eq ratio is at 0.13.
On March 10, 2025, Scotiabank Upgraded its rating to Sector Outperform which previously was Sector Perform but kept the price unchanged to $40.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Apr 01 ’25 when Bellon Christine sold 5,674 shares for $18.35 per share. The transaction valued at 104,122 led to the insider holds 117,294 shares of the business.
Evans John M. sold 30,663 shares of BEAM for $562,684 on Apr 01 ’25. The CEO now owns 986,249 shares after completing the transaction at $18.35 per share. On Apr 01 ’25, another insider, Ciaramella Giuseppe, who serves as the President of the company, sold 7,434 shares for $18.35 each. As a result, the insider received 136,418 and left with 190,216 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 27.92 while its Price-to-Book (P/B) ratio in mrq is 1.58.
Stock Price History:
Over the past 52 weeks, BEAM has reached a high of $35.25, while it has fallen to a 52-week low of $13.52. The 50-Day Moving Average of the stock is -9.95%, while the 200-Day Moving Average is calculated to be -27.41%.
Shares Statistics:
A total of 100.56M shares are outstanding, with a floating share count of 87.47M. Insiders hold about 13.02% of the company’s shares, while institutions hold 87.90% stake in the company.
